Current Clinical Trials at Bay Area Hospital

S1207: Site PI: Bret Cook, MD. Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. Further information available here.

A221102: Site PI: Bret Cook MD. Randomized Double-Blind Placebo-Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women with Aromatase Inhibitor Induced Arthralgias. Further information available here.

2012-PT023: Site PI Bret Cook MD. A Phase III Double-blinded, Placebo Controlled study of Xilonix for Improving Survival in Mesatataic Colorectal Cancer. Further information available here.

ONC-MA-1004: Site PI Bret Cook MD.  A Prospective Observational Cohort Study of Patients with Castration-resistant Prostate Cancer in the United States.  Further information available here

ALCHEMIST: Site PI Bret Cook MD.  Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)  Further information available here.

S1602: Site PI: Leo Kusuda MD. A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG‐Naïve High‐Grade Non‐Muscle Invasive Bladder Cancer. Further information available here.

U13059: Site PI Bret Cook MD.  A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy or Similar Agents for Advanced Cancer: Reducing Toxicity in Older Adults. Further information available here